The uptake of 18F-fluorodeoxyglucose (18F-FDG) by normal breast tissues as measured by a dedicated breast positron emission tomography (PET) scanner: A preliminary study

被引：0
|
作者：
Teo, Sze Yiun [1 ]
Chaal, Jasper [2 ]
Lee, Jung Ah [1 ]
Herranz, Michel [3 ]
机构：
[1] KK Womens & Childrens Hosp, Singapore, Singapore
[2] Agcy Sci Technol & Res, Singapore, Singapore
[3] Univ Santiago de Compostela, Complexo Hosp, Santiago De Compostela, Spain
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P5-01-15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-01-15
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies
    Tian, JH
    Chen, L
    Wei, B
    Shao, MZ
    Ding, Y
    Yin, DY
    Yao, SL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 825 - 831
  • [2] Utility of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in childhood epilepsy.
    Rubi-Sureda, S.
    Setoain, X.
    Rumia, J.
    Seres, E.
    Sanmarti, F.
    Capdevila, A.
    Carreno, M.
    Carrero, E.
    Pons, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S149 - S150
  • [3] Lymphomatous involvement of the gastrointestinal tract:: Evaluation by positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG).
    Phongkitkarun, S
    Varavithya, V
    Kazama, T
    Faria, SC
    Mar, M
    Podoloff, DA
    Macapinlac, HA
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 83P - 83P
  • [4] Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Yamagishi, Yoji
    Koiwai, Tomomi
    Yamasaki, Tamio
    Einama, Takahiro
    Fukumura, Makiko
    Hiratsuka, Miyuki
    Kono, Takako
    Hayashi, Katsumi
    Ishida, Jiro
    Ueno, Hideki
    Tsuda, Hitoshi
    BMC CANCER, 2019, 19 (01)
  • [5] Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Yoji YAMAGISHI
    Tomomi KOIWAI
    Tamio YAMASAKI
    Takahiro EINAMA
    Makiko FUKUMURA
    Miyuki HIRATSUKA
    Takako KONO
    Katsumi HAYASHI
    Jiro ISHIDA
    Hideki UENO
    Hitoshi TSUDA
    BMC Cancer, 19
  • [6] THE ROLE OF 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (18F-FDG PET) IN PEDIATRIC MEDULLARY THYROID CARCINOMA (MTC)
    Bradford, Diana
    Akshintala, Srivandana
    Chen, Clara
    Jung, Seungyeon
    Jones, Elizabeth
    Dombi, Eva
    Whatley, Millie
    Glod, John
    Whitcomb, Trish
    Widemann, Brigitte
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 103 - 103
  • [7] Clinicopathological and prognostic relevance of uptake level revealed by 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Ueda, S.
    Tsuda, H.
    Asakawa, H.
    Omata, J.
    K, Fukatsu
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S60 - S60
  • [8] Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
    Ueda, Shigeto
    Tsuda, Hitoshi
    Asakawa, Hideki
    Shigekawa, Takashi
    Fukatsu, Kazuhiko
    Kondo, Nobuo
    Yamamoto, Mikio
    Hama, Yukihiro
    Tamura, Katsumi
    Ishida, Jiro
    Abe, Yoshiyuki
    Mochizuki, Hidetaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (04) : 250 - 258
  • [9] The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
    Mihailovic, Jasna
    Ubavic, Milan
    VOJNOSANITETSKI PREGLED, 2017, 74 (06) : 571 - 580
  • [10] Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography
    Timmers, Henri J. L. M.
    Chen, Clara C.
    Carrasquillo, Jorge A.
    Whatley, Millie
    Ling, Alexander
    Eisenhofer, Graeme
    King, Kathryn S.
    Rao, Jyotsna U.
    Wesley, Robert A.
    Adams, Karen T.
    Pacak, Karel
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (09) : 700 - 708
12345